Allchorne Paula, Lamb Benjamin W, Kinsella Janette, Shamash Jonathan, Green James S A
Urol Nurs. 2014 Mar-Apr;34(2):95-9.
This study reports the use of intravesical gemcitabine in managing patients with high-risk bladder cancer, refractory to Bacillus Calmette-Guerin (BCG). Patients were given gemcitibine; treatment response was evaluated by fluorescence-cystoscopy biopsy and urine cytology. Time to reoccurrence increased with instillation time.
本研究报告了膀胱内使用吉西他滨治疗卡介苗（BCG）难治性高危膀胱癌患者的情况。给予患者吉西他滨治疗；通过荧光膀胱镜活检和尿液细胞学检查评估治疗反应。复发时间随灌注时间延长而增加。
